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Neuroblastoma (NB), a sympathetically derived childhood tumour, shows characteristics of neuronal precursor cells, suggesting a
halted differentiation process. We have previously shown that the Notch signalling cascade, a key player during normal neurogenesis,
also might be involved in NB differentiation. Valproic acid (VPA), a well-tolerated antiepileptic drug, has been shown to induce
differentiation and cell death of NB cells, possibly associated with its recently described HDAC inhibiting activity. Stimulation of NB
cells with VPA led to increased cell death and phenotypic changes associated with differentiation, that is, neurite extension and
upregulation of neuronal markers. VPA treatment also led to an activated Notch signalling cascade as shown by increased levels of
intracellular Notch-1 and Hes-1, mimicking the initial phase of induced differentiation. These results reinforce that VPA potentially
could be used in differentiation therapy of NB and that the effects in part could be a consequence of interference with the Notch
signalling cascade.
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The paediatric tumour neuroblastoma (NB) is thought to arise due
to perturbed differentiation during development of the sympa-
thetic nervous system (SNS). The cells express molecular markers
transiently expressed during sympathetic development, for exam-
ple, the basic helix–loop–helix (bHLH) proteins Hash-1 and
dHAND (Gestblom et al, 1999; Grynfeld et al, 2000). Spontaneous
regression of a specific subclass of NB, that is, stage 4S, is known to
occur and is a result of differentiation of the tumour cells into
benign ganglioneuroma (Brodeur et al, 1997). The overall survival
rate in NB is low, around 40–50%, and most often the children are
treated with a combination of cytostatics, with frequent relapses of
tumour growth.
The Notch signalling cascade is important in the development of
several tissues, including the peripheral and central nervous
systems (Artavanis-Tsakonas et al, 1999). Notch signalling is
controlled by local cell–cell interactions based on the expression
of Notch receptors and ligands on neighbouring cells that activate
the cascade. This activation most often results in downregulation
of tissue-specific transcriptional activators and the cells are
retained in an undifferentiated state. However, the cellular
response to Notch signalling is highly cell type specific and in
some cases it also triggers a differentiation process (Rangarajan
et al, 2001; Sriuranpong et al, 2001; Schroeder et al, 2003). When
Notch binds to its ligand, Delta-like and Jagged in humans, it goes
through two consecutive cleavages at specific sites: S2 and S3. The
S2 cleavage that occurs just outside the cell membrane is
performed by ADAM-like proteases and exposes the S3 cleavage
site (Val 1744) situated in the transmembrane region. S3 cleavage
is conducted by a g-secretase complex containing presenilin and
results in an activation of the Notch protein by releasing the
intracellular part of the molecule (i.c. Notch), which is then
transported to the nucleus (Mumm and Kopan, 2000). In the
nucleus i.c. Notch binds to RBP-Jk (also referred to as CSL and
CBF-1), which in its quiescent state, binds to co-repressors
mediating a histone deacetylase (HDAC) activity on Notch target
genes (Kao et al, 1998). When i.c. Notch binds to RBP-Jk it
displaces HDAC and the co-repressors and instead transcriptional
co-activators are recruited. One such co-activator is the master-
mind like proteins (MAML), which mediate the interaction with
basal transcriptional activators, such as CBP/p300 (Petcherski and
Kimble, 2000). Thus, the transcriptional activity of RBP-Jk is not
only regulated by complex formation with Notch but also requires
expression of several co-factors.
One direct and important transcriptional target of Notch
signalling is the bHLH protein Hairy and Enhancer of Split-1
(Hes-1) that functions as a negative regulator of transcription (Iso
et al, 2003). Hes-1 binds the promoter region of target genes either
as a homodimer or as a heterodimer together with E proteins and
represses transcription by recruiting Groucho and HDAC through
its N terminal WRPW region (Grbavec and Stifani, 1996; Jimenez
et al, 1997). Hes-1 can also bind to its own promoter, and repress
transcription. One important Hes-1 target gene in neuronal cells is
Mammalian achaete-scute homolog-1 (Mash-1, Hash-1 in humans)
(Chen et al, 1997; Grynfeld et al, 2000). Consequently, Mash-1 is
upregulated in Hes-1 knockout mice and the animals exhibit
premature neuronal differentiation (Sasai et al, 1992). Thus, Notch
signalling is instrumental for proper temporal and spatial neuronal
differentiation. During induced differentiation of NB cells we have
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sobserved a transient upregulation of Hes-1 accompanied by a
downregulation of Hash-1 (Grynfeld et al, 2000). Furthermore,
enforced expression of i.c. Notch-1 inhibits the differentiation
process (Franklin et al, 1999; Grynfeld et al, 2000). Based on these
results we postulate that precise temporal regulation of the Notch
signalling cascade is an integral part of NB cell differentiation from
highly proliferative neuroblasts into terminally differentiated
neuronal cells.
Several lines of evidence indicate that aberrant acetylation of
chromatin can contribute to tumorigenesis (Johnstone, 2002). This
is thought to lead to transcriptional dysregulation of genes that are
involved in important aspects of tumorigenic transformation, such
as differentiation, proliferation and apoptosis. In some tumour
forms, tumour suppressor genes are silenced partly through
deacetylation of promoter regions and treatment with HDAC
inhibitors therefore contribute to re-expression of these genes. A
detailed understanding of the molecular mechanisms behind the
often dramatic effects of HDAC inhibitors on tumour cells remains
unclear.
Valproic acid (VPA) is currently used for long-term treatment of
epilepsy in both adults and children. During recent years it
has become evident that the drug also possesses antitumoural
activity, which has led to several preclinical studies showing
that VPA induces loss of proliferative capacity and promotes
differentiation of several tumour cell types (Blaheta and
Cinatl, 2002). The mechanisms behind these effects are still not
clear, but might involve the ERK-signalling cascade, cell-cycle
regulatory proteins, inhibition of protein kinase C or activation
of PPARg (Yuan et al, 2001; Blaheta and Cinatl, 2002; Gurvich
et al, 2004). One important finding is however that VPA
functions as an HDAC inhibitor, possibly by binding to the
catalytic centre of HDACs (Gottlicher et al, 2001). Furthermore,
it was shown that VPA induced differentiation of F9 teratocarci-
noma and AML cells. In addition, VPA delayed tumour formation
in mouse xenograft experiments (Gottlicher et al, 2001). VPA
has also been shown to suppress the malignant phenotype of
NB cells, indicated by upregulation of some neuronal markers
and decreased cell growth (Cinatl et al, 1997, 2002; Yuan et al,
2001).
In light of the finding that VPA inhibits HDAC activity, we have
studied the effects of the drug on the Notch signalling cascade in
NB cells, since this cascade is dependent of HDAC activity and
seem to play a role in NB cell differentiation. We here report that
VPA induces a more mature phenotype of NB cells along with an
increased activity of the Notch signalling cascade.
MATERIALS AND METHODS
Cell culture
The human NB cell lines SH-SY5Y, SK-N-BE(2) and KCN-69n were
grown in Eagle’s minimum essential medium (Invitrogen Inc.,
Carlsbad, CA, USA) supplemented with 10% foetal calf serum
(FCS), 100IU/ml penicillin and 100mgml
 1 streptomycin in an
atmosphere of 5% CO2. The NB cell line SH-EP derived from SK-
N-SH was grown in the same media and antibiotics as above but
with 15% FCS. IMR-32, LA-N-1, LA-N-2 and LA-N-5 NB cell lines
were cultured in RPMI 1640 with 10% FCS and antibiotics as
above. The rat pheochromocytoma cell line PC12 was grown in
RPMI 1640 supplemented with 10% horse serum, 5% FCS and the
antibiotics as above. SH-SY5Y and SK-N-BE(2) cells were treated
with indicated concentrations of 2-propylpentanoic acid (VPA)
(Sigma, St. Louis, MO, USA) or Trichostatin A (TSA) (Sigma) for
indicated times before harvest. In control experiments equal
volume of solvent was added, that is, methanol or DMSO,
respectively. For inhibition of g-secretase activity, L-685,458
(Bachem) was used at a concentration of 2.5–5mM.
Western blot analysis
Total cell homogenates were prepared by lysing cell pellets in NP40
lysis buffer (1% NP40, 10% glycerol, 20mM Tris-HCl pH 8.0,
137mM NaCl and 4% complete protease inhibitor coctail mix
(Roche, Mannheim, Germany)). In total, 25–50mg protein per lane
was subjected to SDS–PAGE, followed by blotting to PVDF
(Immobilon, Millipore Corp., Billerica, MA, USA) or Hybond C
(Amersham, Life Science, Solna, Sweden) filters. The filters were
probed with polyclonal antiserum directed against the C-terminal
part of Notch-1 diluted 1:50 to 1:100 (#sc-6014, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), polyclonal antiserum
directed against the cleaved form of Notch-1 (Val 1744, Cell
Signaling) diluted 1:500, polyclonal anti-Hes-1 antiserum diluted
1:8000 (kindly provided by Dr Tetsuo Sudo, Japan), monoclonal
anti-Mash-1 antibody diluted 1:125 (Pharmingen, San Diego, CA,
USA) or monoclonal anti-GAPDH antibody diluted 1:500 (Labora
Chemicon International, Temecula, CA, USA). The blots were then
incubated with secondary antibodies: rabbit anti-goat 1:2000
(Dako A/S, Glostrup, Denmark), donkey anti-rabbit 1:1000
(Amersham), goat anti-mouse 1:7000 (Jackson, West Grove, PA,
USA) or sheep anti-mouse 1:5000 (Amersham), all coupled to
horseradish peroxidase. Immunoreactivity was detected using the
enhanced chemiluminescence method (Pierce). For detection of
acetylated histones, cells were treated with 1mM VPA or the
corresponding volume of methanol for 12h. Acidic cell lysates
were separated by SDS–PAGE and transferred to a Hybond C
nitrocellulose membrane (Amersham). Acetylated Histone H3 was
then detected using a polyclonal antiacetyl Histone H3 (Lys9)
antisera diluted 1:500 (Upstate) and a goat anti-rabbit secondary
antibody 1:2000 coupled to horseradish peroxidase (Dako).
Immunoreactivity was detected using the enhanced chemilumi-
nescence method (Pierce). For transient transfection experiments
SK-N-BE(2) cells were seeded 1 day prior to transfection
with expression vectors coding for full length Notch-1 (f.l.
Notch-1) or intracellular Notch-1 (i.c. Notch-1) (Aster et al,
2000), both kindly provided by Dr Jon Aster, USA. As a control
for transfection the empty vector (pcDNA3) was used. In all
experiments 4.8mg DNA and 9ml Lipofectamine 2000 (Life
Technologies, Rockville, MD, USA) were used. The cells were
then treated and harvested as described for Western blot
analyses.
RNA preparation and Northern blotting
The guanidine-isothiocyanate/phenol-chloroform extraction
method was used to isolate total cellular RNA (Chomczynski and
Sacchi, 1987). In total, 15mg RNA was separated on a 1%
formaldehyde agarose gel and blotted onto Hybond-N nylon
membrane (Amersham). A neuropeptide tyrosine (NPY) probe,
generated as described previously (Bjelfman et al, 1990), was
labelled with [
32P]dCTP using an oligonucleotide labelling kit
(Amersham).
RNA purification and cDNA synthesis
Total RNA was purified with RNeasy kit (QIAgen, Hilden,
Germany) as described by the manufacturer where after 2mgo f
RNA was incubated with 2U RNase-free DNase (Promega,
Madison, WI, USA). Samples were desalted and concentrated by
centrifugation on Microcon-100 columns (Amicon, Millipore
Corp., Cork, Ireland). For first strand synthesis 50ng of pd (N) 6
random hexamers (AP Biotech, Freiburg, Germany), 5  first
strand buffer (Invitrogen), 2ml 0.1M DTT (Invitrogen), 40U
Rnasin (Promega), 1ml1 0 m M dNTP mix (AP Biotech) and 1ml
superscript II were added to the purified RNA. The newly
synthesised cDNA was diluted in a final volume of 500ml.
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Real-time quantitative RT–PCR was performed by mixing 2 
master mix (qPCR Core kit for SYBR Green) (Eurogentec, Seraing,
Belgium), 0.75ml C 1/2000 SYBR Green I, 250nM of forward and
reverse primer (Invitrogen) and RNase-free water to a total volume
of 20ml. In total, 5ml of the cDNA template was added and the
reaction mix heated to 951C for 10min. Amplification was carried
out on an ABI5700 (Applied Biosystems) for 40 cycles with a
denaturation temperature of 951C for 15s and annealing and
extension temperature of 601C for 1min. DNase treated RNA was
used as control of the purity of the samples. The genes analysed
were: NPY (forward primer: 50-TCCAGCCCAGAGACACTGATT-30,
reverse primer: 50-AGGGTCTTCAAGCCGAGTTCT-30); GAP-43
(forward primer: 50-ACGACCAAAAGATTGAACAAGATG-30, re-
verse primer: 50-TCCACGGAAGCTAGCCTGAA-30); GAPDH (for-
ward primer: 50-TGCACCACCAACTGCTTAGC 30, reverse primer:
50-GGCATGGACTGTGGTCATGAG -30); HPRT1 (forward primer:
50-TGACACTGGCAAAACAATGCA-30, reverse primer: 50-GGTCCT
TTTCACCAGCAAGCT-30). The results were used to calculate
relative quantity of expression of the different genes, using the
reference genes GAPDH and HPRT1 for normalisation. All
experiments were performed in triplicates and the results were
recorded as relative expression level.
Luciferase reporter assay
SK-N-BE(2) cells were seeded in a 24-well plate 1–2 days prior to
transfection. The cells were then transfected with 20 or 40ng wild-
type Hes-1 promoter construct (kindly provided by Dr Kageyama,
Kyoto University, Japan) (Nishimura et al, 1998) using Lipofecta-
mine 2000 (Life Technologies). After transfection the cells were
treated with either 2.5mM L-685,458, 1 or 2mM VPA, or 50 or
100nM TSA for 24h where after cells were lysed and assayed for
luciferase activity using the Dual-Luciferase Reporter Assay
System according to the manufacturer’s instructions (Promega).
In control experiments equal volume of solvent was added, that is,
methanol and/or DMSO respectively. Experiments were performed
in replicates of three to six and repeated at least twice.
MTT assay
The MTT assays were performed using the Promega CellTiter96
s
Non-Radioactive Cell Proliferation Assay kit according to the
manufacturer’s instructions. In short, drugs were added to a 96-
well cell culture plate prior to seeding SK-N-BE(2) and SH-SY5Y
cells. After 3 days, 10ml dye solution was added to each well and
the plate was incubated for 4h at 371C, 5% CO2. 100ml Lys/Stop
solution was added to each well and allowed to lyse the cells ON at
RT. Next day, the absorbance was read using an ELISA microplate
reader. Each concentration of the drugs was tested in triplicates. In
control experiments equal volume of solvent was added, that is,
methanol or DMSO, respectively.
Flow cytometric analysis
For flow cytometric analysis of cell cycle distribution, both
adherent cells and cells in the culture media were harvested by
centrifugation, resuspended in 70% ethanol ( 201C) and stored at
 201C. Cells were then washed in cold PBS where after 800ml
Vindelo ¨v solution (3.5mM Tris (pH 7.6), 10mM NaCl, 50mgml
 1
propidium iodide, 20mgml
 1 RNase, and 0.1% (volume for
volume) NP-40) was added to the cells and left to incubate for at
least 20min on ice. DNA analyses were performed using a
FACSCalibur flowcytometer (Becton Dickinson Immunocytometry
System, San Jose, CA, USA), and the fraction of G1, S, G2/M and
dead cells was determined using CellQuest 3.2 Software (Becton
Dickinson Immunocytometry System). For assessment of apoptosis,
an apoptosis detection kit labelling cells with FITC-conjugated
annexin V was used as described by the manufacturer (R&D
Systems). In short, cells were stimulated with VPA for 72h where
after cells were harvested, washed twice in cold PBS containing 2%
BSA, and stained with FITC-conjugated annexin V for 15min at
RT. Cells were then washed and annexin V binding analysed by
flow cytometry.
RESULTS
Expression of Notch-1, Hes-1 and Hash-1 in NB cells
The expression patterns of Notch-1, Hes-1 and Hash-1 were
analysed at protein level in NB cell lines and the rat pheochro-
mocytoma cell line PC12 (Figure 1). All cell lines tested expressed
varying levels of Notch-1 (Figure 1). The different bands represent
the full-length protein (approximately 220kDa) and the trans-
membrane protein (approximately 110kDa). As has been shown
previously (Jo ¨gi et al, 2002), all but two NB cell lines expressed
Hash-1 (i.e. SK-N-BE(2), SH-SY5Y, KCN-69, IMR-32, LA-N-1 and
LA-N-2). Hes-1 was detectable in SK-N-BE(2), KCN-69, SH-EP and
PC12 cells. After longer exposure Hes-1 expression could be
detected also in IMR-32 and SH-SY5Y cells (data not shown).
During induced differentiation of NB cells we have previously
reported a transient upregulation of Hes-1 accompanied by a
decrease in the expression of Hash-1 (Grynfeld et al, 2000). Recent
findings indicate that the transient activation of Hes-1 might be
a direct consequence of an increase in Notch signalling activity
(M Stockhausen, manuscript in prep.)
VPA modulates the Notch signalling cascade in NB cells
Next, we wanted to study whether it was possible to affect the
Notch-associated differentiation of NB cells using HDAC inhibi-
tors, since a functional Notch cascade relies on HDAC activity for a
normal function of both RBP-Jk and Hes-1 (Grbavec and Stifani,
1996; Jimenez et al, 1997; Kao et al, 1998). We therefore treated NB
cells with the HDAC inhibitor VPA. In a first experiment we
confirmed the HDAC inhibitory effect of VPA by using an antisera
directed against acetylated histone H3. As expected, treatment with
1m M VPA for 12h led to a dramatic increase in histone H3
acetylation (Figure 2A). Next, SH-SY5Y and SK-N-BE(2) NB cells
were exposed to 0, 1 or 2mM of VPA for 72h and analysed for
expression of proteins within the Notch signalling cascade. Hes-1
protein levels were increased, consistent with the view that Hes-1
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Figure 1 Protein expression analyses of Notch-1, Hes-1 and Hash-1 in
NB cell lines. Cell lysates containing 50mg of protein from the human NB
cell lines SK-N-BE(2), SH-SY5Y, KCN-69n, IMR-32, LA-N-1, LA-N-2, LA-
N-5, SH-EP and the rat pheochromocytoma cell line PC12 were separated
by SDS–PAGE. The proteins were blotted onto a PVDF membrane, which
was probed with polyclonal anti-Notch-1 antiserum, polyclonal anti-Hes-1
antiserum or a monoclonal anti-Mash-1 antibody.
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stranscription normally is repressed by RBP-Jk in complex with co-
repressors and HDAC, which in this setting was inhibited by VPA
(Figure 2B). Even though the Notch-1 levels were unaffected by
VPA, we noticed the appearance of a second faster migrating
Notch-1 band with increasing concentrations of VPA, most likely
representing the g-secretase cleaved, and thereby activated form of
Notch-1, i.c. Notch-1. Since the binding of i.c. Notch-1 to RBP-Jk
has been proposed to be crucial for recruitment of the co-
activating MAML complex (Kitagawa et al, 2001), the induction of
i.c. Notch-1 would act in concert with reduced HDAC activity,
further inducing the expression of Hes-1. Notably, Hash-1, which
is repressed by Hes-1 in complex with Groucho and HDAC, was
decreased upon treatment with VPA (Figure 2B). To further
investigate the effect of VPA on Notch-1 activity we performed
concentration and time course experiments. We could show that
the appearance of the faster migrating Notch-1 band was dose
dependent (Figure 2C). Already, at a relatively low concentration
of VPA (0.5mM), an accumulation of the faster migrating band was
at hand and at 2mM this band was the most prominent. Since it is
known that HDAC inhibitors mediate their effects with rapid
kinetics, we also performed a time course experiment showing that
the faster migrating Notch-1 band started to appear already after
4h and was clearly evident after 8h of treatment with 1mM VPA
(Figure 2D).
In order to assess whether VPA treatment led to increased
cleavage of the Notch-1 receptor, we transfected SK-N-BE(2)
cells with a construct expressing full-length Notch-1 and treated
the cells with 1mM VPA. Using the C-terminal Notch-1 antisera
we could detect an increase in the faster migrating band, indicative
of increased cleavage of the overexpressed protein (Figure 2E).
In control experiments using the g-secretase independent i.c.
Notch-1 construct no obvious changes in the level of the faster
migrating band could be detected. To confirm the identity of the
faster migrating band we also used an antiserum specifically
recognising the S3 cleaved, and hence activated form of the Notch-
1 receptor (Figure 2F). This experiment shows that the faster
migrating band indeed is i.c. Notch-1, and that VPA enhances the
processing of the full-length receptor, but has no clear effect on the
expression of i.c. Notch-1. We could also detect an elevated
expression level of Hes-1 in cells transfected with i.c. Notch-1,
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Figure 2 (A) Western blot analysis showing acetylation of histone H3 after treatment of SK-N-BE(2) cells with 1mM VPA for 12h. (B) Western blot
analysis of Notch-1, Hes-1 and Hash-1 expression in SH-SY5Y and SK-N-BE(2) NB cell lines treated with 1 or 2mM VPA for 72h. (C, D) Western blot
analyses of SK-N-BE(2) cells treated with increasing concentrations of VPA (V) for 24h or with 1mM VPA (V) for indicated times. Untreated cells (C) or cells
treated with the solvent methanol (M) are included as controls. Notch protein expression was detected using an antiserum directed against the C-terminal
domain of the receptor. (E, F) Western blot analyses of SK-N-BE(2) cells transfected with constructs expressing either full-length (f.l. N-1) or intracellular
(i.c. N-1) Notch-1. In control lanes, extracts from untranfected (control) cells or extracts from cells transfected with the empty expression vector were used.
The cells were treated with either 1mM VPA (V) or the solvent methanol (M) for 24h. In (E), antiserum against the C-terminal domain of the Notch-1
receptor was used. Since Notch-1 transfected cells express much higher levels of the Notch-1 protein compared to control cells, shorter exposure of these
lanes is presented. In (F), an antiserum specifically reacting with the cleaved and hence activated form of the receptor was used. In addition, expression of
Hes-1 was analysed. GAPDH was used as a control for equal loading of samples. (G) Hes-1 promoter activity in SK-N-BE(2) cells after treatment with either
VPA alone (1mM) or in combination with the g-secretase inhibitor L-685,458 (2.5mM). Cells were transfected with a vector containing the gene for luciferase
under the control of the Hes-1 promoter. The results are presented as fold induction over control cells and expressed as mean7s.d. of six replicates.
Statistically significant changes were analysed by Student’s t-test.
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swhich was not further enhanced by the addition of VPA
(Figure 2F).
The g-secretase inhibitor L-685,458 inhibits the activating
cleavage (S3) of the Notch receptor and was therefore used to
further dissect the effect of VPA on Notch-1 signalling activity. To
obtain a quantifiable measurement of this effect we performed
luciferase reporter assays using the Hes-1 promoter. The cells were
stimulated with VPA (1mM) alone or in combination with L-
685,458 (2.5mM) (Figure 2G). VPA treatment activated the Hes-1
reporter whereas addition of L-685,458 significantly inhibited this
induction, indicating that VPA induces a g-secretase dependent
activation of Notch signalling (Figure 2G). This notion was further
strengthened in experiments where it was shown that VPA could
enhance the reporter gene activation caused by co-transfection f.l.
Notch-1 and that this effect could be partially repressed by
addition of the g-secretase inhibitor (data not shown). In addition,
to investigate whether also other HDAC inhibitors affect the Notch
signalling cascade, we performed Hes-1 luciferase reporter
experiments after treatment with either VPA or the well-
established HDAC inhibitor TSA. Both treatments led to sub-
stantial activation of the Hes-1 reporter construct in a dose-
dependent manner (Figure 3). In summary, these results indicate
that Notch signalling in NB cells is sensitive to HDAC inhibition
and that VPA also seems to affect the processing of the Notch-1
receptor leading to increased levels of i.c. Notch-1.
VPA decreases the proliferation of NB cells in vitro
Other studies have shown that VPA induces apoptosis and
differentiation of NB cells both in vitro and in vivo (Cinatl et al,
1996, 1997). Based on these observations we performed MTT
assays on SH-SY5Y and SK-N-BE(2) NB cells treated with VPA.
With increasing amounts of VPA a decrease in the number of
respiratory mitochondria, reflecting fewer viable cells, could be
detected in the MTT assay (Figure 4A). Performing the same
experiment with TSA, a similar decrease in the number of viable
cells was observed (Figure 4B). This decrease could either be due to
increased cell death or decreased proliferation, possibly as a result
of induced differentiation. To discriminate between these two
possibilities we performed propidium iodide stainings and FACS
analyses of cell cycle distribution. No significant changes in cell
cycle distribution could be detected (data not shown). When only
attached cells were analysed no increased cell death could be
detected (data not shown). However, when including the culture
media in the analysis, treatment with VPA or TSA led to increased
number of cells in the sub-G1 fraction, reflecting augmented cell
death (Figure 5A and B). These results were further corroborated
using FITC-conjugated annexin V in flow cytometric analyses.
VPA treated cells showed a clear increase in annexin V staining,
indicating increased apoptosis and/or cell death (Figure 5C and D).
Thus, the decrease in the MTT assay was most probably primarily
due to increased cell death. Further analyses of the attached VPA
treated cells using TUNEL staining showed no increased apoptosis
(data not shown). In summary, both VPA and TSA treatment led to
increased cell death in a proportion of the cell population, in line
with previous data (Cinatl et al, 1996, 2002). However, the cells that
remained attached after treatment showed no increased apoptosis.
VPA induces differentiation of NB cells in vitro
With regard to the Notch signalling cascade, VPA treatment of NB
cells led to changes similar to the ones observed when neuronal
differentiation is induced by RA or TPA (Grynfeld et al, 2000; Jo ¨gi
et al, 2002). In line with this notion, the morphology of VPA
treated NB cells changed towards a more flattened phenotype with
longer neurite extensions (Figure 6 and data not shown). To
further characterise this phenotype we analysed the expression of
some marker genes associated with neuronal/neuroendocrine
differentiation using Northern blotting and real-time quantitative
RT–PCR. A significant increase in NPY expression was detected
using Northern blotting (Figure 7B). In the real time RT–PCR
analyses this increase was shown to be several-fold (Figure 7A).
Also, GAP-43 expression was clearly induced when NB cells were
treated with VPA (Figure 7A). These findings support previous
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sreports by Cinatl et al (1997, 2002), suggesting that VPA induces
both differentiation and cell death of human NB cells. Interest-
ingly, the upregulation of NPY caused by VPA could be partially
suppressed by the g-secretase inhibitor L-685,458 (Figure 7C). This
indicates that at least some of the differentiation-inducing effect of
VPA might be a consequence of increased cleavage of the Notch
receptor.
DISCUSSION
Dysregulation of the Notch pathway has been implicated in several
neoplasms (Allenspach et al, 2002). The consequences of such
dysregulation does however seem to be highly cell type specific.
For example, the constitutively activated form of Notch acts as a
bona fide oncogene in leukaemia and in murine breast cancer,
while recent data show that Notch-1 can function as a tumour
suppressor gene in skin cancer (Ellisen et al, 1991; Uyttendaele
et al, 1996; Nicolas et al, 2003). It has been suggested that these
disparate effects might be dependent of the normal function of the
cascade, that is, in tissues were Notch signalling is active in
progenitor cells followed by a decreased signalling in differentiated
cells, a constitutive activation of the cascade might lead to blocked
differentiation or increased survival and proliferation (Allenspach
et al, 2002). In other tissues, where Notch signalling is required for
differentiation, exemplified by keratinocytes, loss of Notch activity
might contribute to tumour development (Allenspach et al, 2002;
Nicolas et al, 2003). Since Notch signalling is important during the
embryonal development of the SNS, where it inhibits neuronal
differentiation to take place prematurely, it seems likely that any
dysregulated activity of this cascade would contribute to main-
taining the cells in an undifferentiated, proliferating stage.
Neuroblastoma represents an almost unique tumour cell type in
its capacity to differentiate upon treatment with different types of
inducing agents, upregulating a well-established set of differentia-
tion marker genes, making it possible to monitor the differentia-
tion process (Pa ˚hlman et al, 1984, 1991; Bjelfman et al, 1990). We
have previously shown that most NB cell lines express Hash-1 and
that the expression of Hes-1 is transiently increased upon induced
differentiation with a concomitant decrease in Hash-1 expression
(Grynfeld et al, 2000). In this report we show that all NB cell lines
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Figure 6 Morphology of VPA treated SK-N-BE(2) NB cells. SK-N-BE(2)
NB cells were transfected with empty pCMS-EGFP vector and treated with
1o r2m M VPA for 72h. Transiently transfected cells expressing EGFP were
identified by fluorescence microscopy.
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sexpress varying levels of Notch-1 (Figure 1). We, and others, have
shown that Hes-1 can bind to the N-box in the Hash-1 promoter
and thereby repress Hash-1 transcription (Chen et al, 1997;
Grynfeld et al, 2000). Since Hes-1 expression is under direct
control of the Notch receptors, it is possible that these events are
regulated by changes in Notch signalling activity during the
differentiation process of NB cells. Our data suggest that during
the initial phase of differentiation the Notch signalling cascade is
activated. This leads to a rapid downregulation of Hash-1,
accompanied by an upregulation of neuronal marker genes. These
early events are followed by neurite outgrowth and cessation of
proliferation. At this stage, Notch-1, Hes-1 and Hash-1 are all
downregulated, possibly reflecting a terminally differentiated
sympatho-adrenal phenotype.
We speculate that it can be possible to affect the proliferation
capacity and differentiation status of NB cells by interfering with
the Notch cascade. This could be achieved by specific interference
with Notch activation. An alternative approach is to interfere with
the intracellular components of the Notch cascade. Since
transcriptional repression, in part mediated by HDAC activity,
plays a pivotal role in the Notch cascade we have studied the effects
of VPA on Notch signalling in NB cells. It has been known for two
decades that VPA can inhibit tumour growth, and several
preclinical studies on a wide variety of tumours have been
performed (Blaheta and Cinatl, 2002). In a mouse NB cell line it
was shown that VPA to a certain extent inhibits proliferation and
VPA in combination with IFN-a led to neuronal differentiation of
human NB cells (Cinatl et al, 2002). Furthermore, in xenograft
experiments in mouse, VPA was shown to decrease tumour growth
combined with a more differentiated phenotype of the NB cells
(Cinatl et al, 1997, 2002). The mechanisms behind these effects
remained elusive until recent findings showed that VPA is a potent
HDAC inhibitor and that induced differentiation of carcinoma and
leukaemic cells could be associated to this activity (Gottlicher et al,
2001).
It has been shown that VPA treatment of SH-SY5Y cells leads to
activation of the MAP kinase signalling pathway, which in turn
leads to induction of the AP-1 transcription factor (Yuan et al,
2001). Accordingly, several differentiation-related genes known to
be activated by AP-1 was induced, such as growth cone associated
protein 43 (GAP-43) and Bcl-2. By using different inhibitors the
authors could show that this effect of VPA was specifically
mediated by the ERK pathway. This is of particular interest with
respect to the effect of VPA on the Notch signalling cascade, since
there seem to be a mutual influence between ERK signalling and
the Notch pathway. For example, in T-cell leukaemia it was shown
that Notch-induced transformation required the activation of MAP
kinase and PI-3 kinase activity (Fitzgerald et al, 2000). Conversely,
it was shown that activation of Notch signalling was an obligate
step in Ras-induced transformation in an experimental system
using human fibroblasts (Weijzen et al, 2002). However, we only
detected very modest activation of the ERK pathway upon VPA
treatment (data not shown). This discrepancy is probably due to
the fact that we have performed our experiments during full serum
stimulation. In our experimental set up it is therefore less likely
that the dramatic effect on Notch signalling upon VPA treatment is
a direct consequence of ERK activation. It is however known that
Hes-1 is particularly sensitive to mitogenic stimulation and further
studies are required to dissect whether some of the effects reported
here in part might be a consequence of MAP kinase activation.
In this study we show that VPA causes changes of the Notch
signalling cascade similar to changes detected during the early
stages of TPA or RA induced differentiation of NB cells (Figure 2B)
(Grynfeld et al, 2000). We noted increased levels of Hes-1 and
decreased levels of Hash-1. The increased levels of Hes-1 could be
due to the HDAC inhibiting effect of VPA, which would inhibit the
repressive effect of RBP-Jk on Hes-1 expression, or alternatively by
affecting other associated factors such as MAML. The decreased
level of Hash-1, on the other hand, might seem more paradoxical
since Hes-1 is known to repress transcription from the Hash-1
promoter by recruiting Groucho and HDAC, which is inhibited by
VPA (Chen and Courey, 2000). It was however recently shown that
Hes-1 could repress transcription of target genes by an additional,
TSA insensitive, HDAC called SIRT. SIRT and Groucho/HDAC
were proposed to operate synergistically since they bind different
regions of Hes-1 (the bHLH domain and the C-terminal tetra
peptide motif, respectively) (Takata and Ishikawa, 2003). Thus, the
decrease in Hash-1 levels in the presence of the HDAC inhibitor
VPA might be due to additional repression by SIRT. Hash-1
expression might however be regulated on several levels. For
example, in small cell lung cancer it has been shown that Notch-1
induces degradation of the Hash-1 protein (Sriuranpong et al,
NPY
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Figure 7 Differentiation status of VPA treated SH-SY5Y and SK-N-
BE(2) NB cells. (A) Real-time quantitative RT–PCR analyses of NB cells
treated with 1 or 2mM VPA for 72h showing NPY and GAP-43 mRNA
expression. Data are presented as relative expression levels using GAPDH
and HPRT1 as reference genes. Experiments were performed in triplicates
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relative expression level using GAPDH and HPRT1 as reference genes.
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s2002). Alternatively, the decreased Hash-1 expression after VPA
treatment might solely reflect a more differentiated phenotype.
We also noted that VPA seems to affect the level of Notch-1
activation since we observed an accumulation of the activated form
of the receptor, i.c. Notch-1 in Western blot experiments (Figure 2).
We could show that this accumulation was rather rapid, with an
increase in the level of cleaved Notch-1 starting already after 4h
and that it was concentration dependent. In addition, using cells
transfected with Notch-1 constructs we could show that VPA
treatment led to elevated levels of the active form of the receptor.
The mechanisms behind these findings are currently unclear. It
might however be speculated that it involves increased activity of
the g-secretase complex. Using a Hes-1 luciferase reporter assay we
could show that VPA induced a substantial activation of the
promoter and that this activation could be suppressed by the g-
secretase inhibitor L-685,458 (Figure 2G). Whether these results
reflects an increased Notch signalling activity or alleviation of the
HDAC-dependent repression of the Hes-1 promoter remains to be
determined. Thus, VPA might affect the Notch signalling cascade
at different levels simultaneously.
The VPA induced changes in the Notch cascade described
above, are similar to the changes in Notch signalling noticed
during the initial phase of RA- or TPA-induced differentiation.
This notion was substantiated by the findings that two well-
established neuronal marker genes, NPY and GAP-43 were
upregulated and by changes in morphology (Figure 6 and 7). We
suggest that these events reflect a partial induction towards a more
differentiated phenotype. A clear increase in cell death was also
noted upon treatment with VPA (Figures 4 and 5), in line with data
presented in previous reports (Cinatl et al, 1997).
The Notch signalling cascade represents an appealing target for
tumour cell differentiation therapy. We show here that the well-
tolerated HDAC inhibitor VPA can be used to modulate the Notch
signalling cascade in NB cells and that this can lead to induced
differentiation together with increased cell death. These findings
might explain some of the antitumorigenic effects of VPA.
ACKNOWLEDGEMENTS
We would like to thank Dr Ingrid Øra for kind help in establishing
MTT assays. HA has a Childrens Cancer Foundation of Sweden
research position. This paper was supported by grants from the
Swedish Cancer Society, the Children’s Cancer Foundation of
Sweden, Ollie and Elof Ericsson’s Foundation, A ˚ke Wiberg’s
Foundation, the Crafoord Foundation and Malmo ¨ University
Hospital Research Funds.
REFERENCES
Allenspach EJ, Maillard I, Aster JC, Pear WS (2002) Notch signaling in
cancer. Cancer Biol Ther 1: 466–476
Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate
control and signal integration in development. Science 284: 770–776
Aster JC, Xu L, Karnell FG, Patriub V, Pui JC, Pear WS (2000) Essential
roles for ankyrin repeat and transactivation domains in induction of
T-cell leukemia by notch1. Mol Cell Biol 20: 7505–7515
Bjelfman C, Meyerson G, Cartwright CA, Mellstrom K, Hammerling U,
Pa ˚hlman S (1990) Early activation of endogenous pp60src kinase activity
during neuronal differentiation of cultured human neuroblastoma cells.
Mol Cell Biol 10: 361–370
Blaheta RA, Cinatl Jr J (2002) Anti-tumor mechanisms of valproate: a novel
role for an old drug. Med Res Rev 22: 492–511
Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS (1997)
Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol
19: 93–101
Chen G, Courey AJ (2000) Groucho/TLE family proteins and transcriptional
repression. Gene 249: 1–16
Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD,
Baylin SB, Ball DW (1997) Conservation of the Drosophila lateral in-
hibition pathway in human lung cancer: a hairy-related protein (HES-1)
directly represses achaete-scute homolog-1 expression. Proc Natl Acad
Sci USA 94: 5355–5360
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by
acid guanidinium thiocyanate–phenol–chloroform extraction. Anal
Biochem 162: 156–159
Cinatl Jr J, Cinatl J, Driever PH, Kotchetkov R, Pouckova P, Kornhuber B,
Schwabe D (1997) Sodium valproate inhibits in vivo growth of human
neuroblastoma cells. Anticancer Drugs 8: 958–963
Cinatl Jr J, Cinatl J, Scholz M, Driever PH, Henrich D, Kabickova H, Vogel
JU, Doerr HW, Kornhuber B (1996) Antitumor activity of sodium
valproate in cultures of human neuroblastoma cells. Anticancer Drugs 7:
766–773
Cinatl Jr J, Kotchetkov R, Blaheta R, Driever PH, Vogel JU, Cinatl J (2002)
Induction of differentiation and suppression of malignant phenotype of
human neuroblastoma BE(2)-C cells by valproic acid: enhancement by
combination with interferon-alpha. Int J Oncol 20: 97–106
Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J
(1991) TAN-1, the human homolog of the Drosophila notch gene, is
broken by chromosomal translocations in T lymphoblastic neoplasms.
Cell 66: 649–661
Fitzgerald K, Harrington A, Leder P (2000) Ras pathway signals are
required for notch-mediated oncogenesis. Oncogene 19: 4191–4198
Franklin JL, Berechid BE, Cutting FB, Presente A, Chambers CB, Foltz DR,
Ferreira A, Nye JS (1999) Autonomous and non-autonomous regulation
of mammalian neurite development by Notch1 and Delta1. Curr Biol 9:
1448–1457
Gestblom C, Grynfeld A, Ora I, Ortoft E, Larsson C, Axelson H, Sandstedt B,
Cserjesi P, Olson EN, Pa ˚hlman S (1999) The basic helix–loop–helix
transcription factor dHAND, a marker gene for the developing human
sympathetic nervous system, is expressed in both high- and low-stage
neuroblastomas. Lab Invest 79: 67–79
Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman
JP, Lo Coco F, Nervi C, Pelicci PG, Heinzel T (2001) Valproic acid defines
a novel class of HDAC inhibitors inducing differentiation of transformed
cells. EMBO J 20: 6969–6978
Grbavec D, Stifani S (1996) Molecular interaction between TLE1 and the
carboxyl-terminal domain of HES-1 containing the WRPW motif.
Biochem Biophys Res Commun 223: 701–705
Grynfeld A, Pa ˚hlman S, Axelson H (2000) Induced neuroblastoma cell
differentiation, associated with transient HES-1 activity and reduced
HASH-1 expression, is inhibited by Notch1. Int J Cancer 88: 401–410
Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS (2004) Histone
deacetylase is a target of valproic acid-mediated cellular differentiation.
Cancer Res 64: 1079–1086
Iso T, Kedes L, Hamamori Y (2003) HES and HERP families: multiple
effectors of the Notch signaling pathway. J Cell Physiol 194: 237–255
Jimenez G, Paroush Z, Ish-Horowicz D (1997) Groucho acts as a
corepressor for a subset of negative regulators, including Hairy and
Engrailed. Genes Dev 11: 3072–3082
Jo ¨gi A, Persson P, Grynfeld A, Pa ˚hlman S, Axelson H (2002) Modulation of
basic helix–loop–helix transcription complex formation by Id proteins
during neuronal differentiation. J Biol Chem 277: 9118–9126
Johnstone RW (2002) Histone-deacetylase inhibitors: novel drugs for the
treatment of cancer. Nat Rev Drug Discov 1: 287–299
Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner
CR, Evans RM, Kadesch T (1998) A histone deacetylase corepressor
complex regulates the Notch signal transduction pathway. Genes Dev 12:
2269–2277
Kitagawa M, Oyama T, Kawashima T, Yedvobnick B, Kumar A, Matsuno K,
Harigaya K (2001) A human protein with sequence similarity to
Drosophila mastermind coordinates the nuclear form of notch and a
CSL protein to build a transcriptional activator complex on target
promoters. Mol Cell Biol 21: 4337–4346
Mumm JS, Kopan R (2000) Notch signaling: from the outside in. Dev Biol
228: 151–165
HDAC inhibition and Notch signalling
M-T Stockhausen et al
758
British Journal of Cancer (2005) 92(4), 751–759 & 2005 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sNicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC,
Clevers H, Dotto GP, Radtke F (2003) Notch1 functions as a tumor
suppressor in mouse skin. Nat Genet 33: 416–421
Nishimura M, Isaka F, Ishibashi M, Tomita K, Tsuda H, Nakanishi S,
Kageyama R (1998) Structure, chromosomal locus, and promoter of
mouse Hes2 gene, a homologue of Drosophila hairy and Enhancer of
split. Genomics 49: 69–75
Pa ˚hlman S, Meyerson G, Lindgren E, Schalling M, Johansson I (1991)
Insulin-like growth factor I shifts from promoting cell division to
potentiating maturation during neuronal differentiation. Proc Natl Acad
Sci USA 88: 9994–9998
Pa ˚hlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T (1984)
Retinoic acid-induced differentiation of cultured human neuroblastoma
cells: a comparison with phorbolester-induced differentiation. Cell Differ
14: 135–144
Petcherski AG, Kimble J (2000) Mastermind is a putative activator for
Notch. Curr Biol 10: R471–R473
Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H,
Aster JC, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke F,
Dotto GP (2001) Notch signaling is a direct determinant of keratinocyte
growth arrest and entry into differentiation. EMBO J 20: 3427–3436
Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S (1992) Two
mammalian helix–loop–helix factors structurally related to Drosophila
hairy and Enhancer of split. Genes Dev 6: 2620–2634
Schroeder T, Kohlhof H, Rieber N, Just U (2003) Notch signaling induces
multilineage myeloid differentiation and up-regulates PU.1 expression.
J Immunol 170: 5538–5548
Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB,
Ball DW (2001) Notch signaling induces cell cycle arrest in small cell lung
cancer cells. Cancer Res 61: 3200–3205
Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN,
Blaumueller CM, Nelkin BD, Ball DW (2002) Notch signaling
induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol
22: 3129–3139
Takata T, Ishikawa F (2003) Human Sir2-related protein SIRT1 associates
with the bHLH repressors HES1 and HEY2 and is involved in HES1- and
HEY2-mediated transcriptional repression. Biochem Biophys Res Com-
mun 301: 250–257
Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J (1996)
Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific
mammalian Notch gene. Development 122: 2251–2259
Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne
BA, Gottipati S, Aster JC, Hahn WC, Rudolf M, Siziopikou K, Kast WM,
Miele L (2002) Activation of Notch-1 signaling maintains the neoplastic
phenotype in human Ras-transformed cells. Nat Med 8: 979–986
Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G (2001) The
mood stabilizer valproic acid activates mitogen-activated protein kinases
and promotes neurite growth. J Biol Chem 276: 31674–31683
HDAC inhibition and Notch signalling
M-T Stockhausen et al
759
British Journal of Cancer (2005) 92(4), 751–759 & 2005 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
s